Mineralization pattern of vertebral bone material following fragility fracture of the spine.
Little is known whether trabecular bone matrix mineralization is altered at the site of osteoporotic vertebral fractures. Bone mineralization density distribution (BMDD) was assessed in trabecular bone of acute, single-level compression fractures of the spine at various stages of fracture repair using quantitative backscattered electron imaging (qBEI). The grading of the repair stage was performed by histological methods. From 20 patients, who underwent either kyphoplasty (n=18) or vertebroplasty (n=2), a vertebral bone biopsy was taken prior to cement augmentation. Six patients took bisphosphonates (BP) prior to fracture. Three study groups were formed: N1=early-, N2=late-healing and B=BP treatment at late healing stage. In general, all groups had an altered BMDD when compared to historical normative reference data. Mean matrix mineralization (CaMean) was significantly (p<0.001) lower in all groups (N1: -5%, N2: -16%, and B2: -16%). In N2, CaMean was -13.1% (p<0.001) lower than N1. At this stage, deposition of new bone matrix and/or formation of woven bone are seen, which also explains the more heterogeneous matrix mineralization (CaWidth). Moreover, BP treatment (B2) led to a significant reduction in CaWidth (-28.5%, p<0.001), when compared to N2. Bone tissue from vertebrae with acute compression fractures reveals a large variation in matrix mineralization depending on the stage of repair. Bisphosphonate treatment does affect the mineralization pattern of tissue repair. The low mineralization values found in early stage of repair suggest that altered bone material properties may play a role in the occurrence of fragility fractures of the spine.
Ludwig Boltzmann Institute of Osteology at Hanusch Hospital of WGKK and AUVA Trauma Centre Meidling, 1st Medical Department Hanusch Hospital, Vienna, Austria. jochen.hofstaetter@meduniwien.ac.at
Jochen G
JG
Hofstaetter
Stefan G
SG
Hofstaetter
Kamilla
K
Nawrot-Wawrzyniak
Helmut
H
Hiertz
Josef G
JG
Grohs
Klemens
K
Trieb
Reinhard
R
Windhager
Klaus
K
Klaushofer
Paul
P
Roschger
D000368:Aged; D001706:Biopsy; D002113:Calcification, Physiologic / Q000502:physiology*; D004164:Diphosphonates / Q000627:therapeutic use; D005260:Female; D017102:Fracture Healing / Q000502:physiology*; D050815:Fractures, Compression / Q000145:classification / Q000473:pathology / Q000503:physiopathology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010024:Osteoporosis / Q000473:pathology / Q000503:physiopathology*; D016103:Spinal Fractures / Q000145:classification / Q000473:pathology / Q000503:physiopathology*
D004164:Diphosphonates